ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.
New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...
Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.
National Centre for Disease Control formed panel to discuss such vaccinations through Universal Immunization Programme. Evidence being gathered to present to NTAGI, it is learnt.
VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.
The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.
COMMENTS